Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BETAEVAL_Global- The New BETACONNECT® Auto-injector: Adherence and EVALuation of MS Patients Treated With Betaferon®

NCT02247310 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02247310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02247310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BETAEVAL_Global- The New BETACONNECT® Auto-injector: Adherence and EVALuation of MS Patients Treated With Betaferon®
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
October 20, 2014
Completion date
November 8, 2016
Enrollment
498 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, relapsing remitting